Phase 2a Topical Sildenafil Proof-of-Concept Study in Men With Mild to Moderate ED
Condition(s):Erectile DysfunctionLast Updated:October 12, 2017Completed
Hide Studies Not Open or Pending
Condition(s):Erectile DysfunctionLast Updated:October 12, 2017Completed
Condition(s):AML, AdultLast Updated:February 16, 2024Not yet recruiting
Condition(s):Prostate Cancer MetastaticLast Updated:May 12, 2022Completed
Condition(s):Obesity; Bariatric Surgery; Morbid Obesity; Diabetes Mellitus Type 2; Diet TherapyLast Updated:December 17, 2019Terminated
Condition(s):Cervical Cancer; ScreeningLast Updated:March 8, 2024Recruiting
Condition(s):Premature Coronary Heart DiseaseLast Updated:October 8, 2020Unknown status
Condition(s):Neonatal Opioid Withdrawal SyndromeLast Updated:February 28, 2024Active, not recruiting
Condition(s):InfertilityLast Updated:October 23, 2023Not yet recruiting
Condition(s):HR+/HER2- Locally Advanced, Metastatic Breast CancerLast Updated:March 17, 2023Completed
Condition(s):Human Epidermal Growth Factor 2 Negative Carcinoma of BreastLast Updated:January 30, 2013Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.